(Q28373805)

English

The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group

scientific article

Statements

The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group (English)
0 references
R A Rodby
0 references
R D Rohde
0 references
W R Clarke
0 references
L G Hunsicker
0 references
D A Anzalone
0 references
R C Atkins
0 references
E Ritz
0 references
E J Lewis
0 references
April 2000
0 references
15
0 references
4
0 references
487-97
0 references

Identifiers

0 references
0 references
 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit